← The Wire
KURANasdaq
Kura Oncology, Inc.
Pharmaceutical Preparations · DE · CIK 1422143
Develops targeted small-molecule cancer therapies for oncology and hematology
red 8-K · 90d
$803M
Market cap
$10.97
Last close
+0.6%
1D
+5.9%
5D
1.2M
Volume
Price · last 39 sessions+18.6%
May 4L $8.56 · H $11.25Jun 29
292
Total filings
Jun 4, 2026
Last filing
12/31
Fiscal year end
8-KExecutive Change · Shareholder VoteJun 4, 2026DEFA14ADEFA14AMay 26, 202610-Q10-QMay 12, 20268-KResults of OperationsMay 12, 2026DEFA14ADEFA14AApr 10, 2026DEF 14ADEF 14AApr 10, 202610-K10-KMar 5, 20268-KResults of OperationsMar 5, 20268-KBylaw AmendmentJan 29, 20268-KResults of OperationsJan 12, 20268-KCompany UpdateDec 2, 20258-KCompany UpdateNov 13, 202510-Q10-QNov 4, 20258-KResults of OperationsNov 4, 20258-KCompany UpdateOct 24, 20258-KCompany UpdateOct 16, 202510-Q10-QAug 7, 20258-KResults of OperationsAug 7, 20258-KMaterial AgreementJul 1, 20258-KCompany UpdateJun 18, 20258-KExecutive Change · Shareholder VoteJun 6, 20258-KCompany UpdateJun 3, 202510-Q10-QMay 1, 20258-KResults of OperationsMay 1, 2025DEFA14ADEFA14AApr 11, 2025DEF 14ADEF 14AApr 11, 202510-K10-KFeb 28, 20258-KResults of OperationsFeb 26, 20258-KCompany UpdateFeb 5, 20258-KMaterial Agreement · New Debt / ObligationJan 14, 20258-KExecutive Change · Company UpdateJan 6, 20258-KCompany UpdateDec 20, 2024SC 13GSC 13GDec 5, 20248-KMaterial AgreementNov 20, 202410-Q10-QNov 7, 20248-KResults of OperationsNov 7, 20248-KExecutive ChangeSep 17, 202410-Q10-QAug 8, 20248-KResults of OperationsAug 8, 20248-KExecutive Change · Shareholder VoteJun 7, 20248-KCompany UpdateMay 24, 2024SC 13GSC 13GMay 2, 202410-Q10-QMay 2, 20248-KResults of OperationsMay 2, 2024DEFA14ADEFA14AApr 12, 2024DEF 14ADEF 14AApr 12, 202410-K10-KFeb 27, 20248-KResults of OperationsFeb 27, 20248-KResults of Operations · Company UpdateJan 30, 20248-KMaterial Agreement · Equity IssuanceJan 26, 20248-KCompany UpdateDec 22, 202310-Q10-QNov 2, 20238-KResults of OperationsNov 2, 2023SC 13GSC 13GSep 21, 20238-KMaterial AgreementSep 1, 202310-Q10-QAug 9, 20238-KResults of OperationsAug 3, 20238-KCompany UpdateJun 14, 2023424B5424B5Jun 14, 2023424B5424B5Jun 13, 20238-KCompany UpdateJun 12, 20238-KExecutive Change · Shareholder VoteJun 2, 202310-Q10-QMay 10, 20238-KResults of OperationsMay 10, 2023DEFA14ADEFA14AMay 4, 20238-KCompany UpdateApr 19, 2023DEFA14ADEFA14AApr 6, 2023DEF 14ADEF 14AApr 6, 20238-KReg FD DisclosureMar 10, 202310-K10-KFeb 23, 20238-KResults of OperationsFeb 23, 2023SC 13GSCHEDULE 13GFeb 9, 20238-KExecutive ChangeJan 13, 20238-KResults of Operations · Company UpdateJan 9, 20238-KCompany UpdateDec 12, 2022SC 13GTHE SCHEDULE 13GDec 5, 20228-KCompany UpdateNov 3, 202210-Q10-QNov 3, 20228-KResults of OperationsNov 3, 20228-KMaterial Agreement · New Debt / ObligationNov 3, 2022
Insider Activity
In the 90 days to Jan 27, 2026: 7 sold $1.1M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 27, 2026 | Powl Brian T.Chief Commercial Officer | Sell | 4,842 | $8.46 | $41K |
| Jan 27, 2026 | Bair Teresa BrophyChief Legal Officer | Sell | 4,777 | $8.46 | $40K |
| Jan 27, 2026 | Bair Teresa BrophyChief Legal Officer | Sell | 4,096 | $8.46 | $35K |
| Jan 27, 2026 | Leoni MollieChief Medical Officer | Sell | 3,655 | $8.46 | $31K |
| Jan 27, 2026 | Bair Teresa BrophyChief Legal Officer | Sell | 2,335 | $8.46 | $20K |
| Jan 27, 2026 | Leoni MollieChief Medical Officer | Sell | 2,233 | $8.46 | $19K |
| Jan 27, 2026 | Doyle Thomas JamesSVP, Finance & Accounting | Sell | 2,226 | $8.46 | $19K |
| Jan 27, 2026 | Ford KathleenChief Operating Officer | Sell | 1,813 | $8.46 | $15K |
| Jan 27, 2026 | Powl Brian T.Chief Commercial Officer | Sell | 1,572 | $8.46 | $13K |
| Jan 27, 2026 | Leoni MollieChief Medical Officer | Sell | 1,341 | $8.46 | $11K |
| Jan 27, 2026 | Burrows FrancisChief Scientific Officer | Sell | 1,311 | $8.46 | $11K |
| Jan 27, 2026 | Doyle Thomas JamesSVP, Finance & Accounting | Sell | 1,114 | $8.46 | $9K |
| Jan 27, 2026 | Leoni MollieChief Medical Officer | Sell | 951 | $8.46 | $8K |
| Jan 27, 2026 | Doyle Thomas JamesSVP, Finance & Accounting | Sell | 881 | $8.46 | $7K |
| Jan 27, 2026 | Doyle Thomas JamesSVP, Finance & Accounting | Sell | 695 | $8.46 | $6K |
| Dec 18, 2025 | Burrows FrancisChief Scientific Officer | Sell | 23,726 | $9.78 | $232K |
| Dec 9, 2025 | Hasnain FaheemDirector | Sell | 10,000 | $10.98 | $110K |
| Nov 14, 2025 | Leoni MollieChief Medical Officer | Sell | 15,485 | $11.18 | $173K |
| Nov 14, 2025 | Powl Brian T.Chief Commercial Officer | Sell | 8,887 | $11.18 | $99K |
| Nov 14, 2025 | Bair Teresa BrophyChief Legal Officer | Sell | 8,804 | $11.18 | $98K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance